key: cord-0715368-q1h64h99 authors: Nicosia, Luca; Bozzini, Anna Carla; Latronico, Antuono; Addante, Francesca; Mastropasqua, Mauro Giuseppe; Meneghetti, Lorenza; Mauri, Giovanni; De Fiori, Elvio; Montesano, Marta; Di Tonno, Clementina; Midolo De Luca, Valeria; Casadio, Chiara; Cassano, Enrico title: COVID‐19 and breast fine needle aspiration cytology method: What should we change? date: 2021-03-11 journal: Cytopathology DOI: 10.1111/cyt.12959 sha: 3a4f7e886bf01a4f86ff4d3433c7857411295fba doc_id: 715368 cord_uid: q1h64h99 INTRODUCTION: Air‐dried slide preparation for fine needle aspiration cytology procedures is currently considered unsafe because of the risk of infectious aerosols of coronavirus 19. This study compares the safety and accuracy of two different protocols, one with and one without air‐dried slides. METHODS: Starting from 3 March 2020, we discontinued the use of air‐dried slides during breast fine needle aspiration procedures. We selected cases collected during two periods: 2 months before and 2 months after 3 March. In both groups, the number of procedures was recorded together with the distribution of the diagnostic categories and the concordance between cytological and histological results on surgical specimens for lesions suggestive of malignancy, using the chi‐squared test. RESULTS: Of the 100 procedures performed during the pre‐COVID‐19 period, 55% were negative (C2), 3% were non‐diagnostic (C1) and 40% were positive (C4 or C5). Of the 75 procedures obtained during the COVID‐19 period, 44% were negative (C2), 2.7% were non‐diagnostic (C1) and 52% were positive (C4 or C5). Despite the use of a new protocol during the COVID‐19 period, we observed concordance between cytological and histological results for lesions suggestive of malignancy. There was no statistically significant difference concerning the distribution of the diagnostic categories in the two groups. CONCLUSIONS: Taking into account the slightly lower number of procedures being analysed during the COVID‐19 period, the introduction of a new protocol that does not include air‐dried slides is safe and reliable. Fine needle aspiration cytology (FNAC) has been an essential step in the evaluation of breast lesions since 1968, when Franzen and Zajicek published the first series of cytology results based on 2111 patients, obtaining excellent results. 1 FNAC has been confirmed as an excellent method for the diagnosis of both palpable and non-palpable lesions, under ultrasound guidance, with satisfactory levels of sensitivity and specificity. 2, 3 In comparison to other breast diagnostic procedures, FNAC has many advantages: it can be performed in the outward clinic, most of the equipment needed for a high-quality product is low-priced and readily available, results are generally available in a few hours with a low rate of complications and good patient tolerability. 4, 5 In most breast oncology centres, standard FNAC slide production consists of preparing a thin smear of aspirated material, avoiding crush artefacts. The slides are rapidly air-dried and quickly fixed in 95% ethanol. 6 However, since the outbreak and dramatic spread in the north of Italy of coronavirus disease 2019 (COVID-19), 7,8 the preparation of air-dried slides has become a risky procedure due to the aerosols of potentially infectious material. Specimen processing should follow biosafety level 2 guidelines with personal protective equipment at all times. [9] [10] [11] Further, the risk of infection of mucous membranes of the nose, eyes or mouth from potential COVID-19 contamination of dry surfaces is also a complication. 12, 13 In contrast, alcohol-fixed smears significantly reduce coronavirus infectivity 14 and so are preferred over air-dried smears. In accordance with this, our Breast Unit at the European Institute of Oncology (Milan, Lombardy, the epicentre of the pandemic area), decided to change the FNAC protocol avoiding air-dried slides, in favour of an alcohol-based method. Samples were ethanol fixed to avoid the production of potentially infectious aerosols during the expulsion of material onto slides for air drying. However, to ensure diagnostic accuracy of the procedure, we aimed to verify the efficacy of this new protocol compared to the standard one. We have retrospectively analysed all breast ultrasound-guided FNACs for suspicious lesions performed between January 2020 and May 2020 in our Breast unit. The cut-off between the old and the new protocols was 3 March. Selected cases were from routine screening and follow-up programmes or symptomatic patients, provided they presented visible lesions on ultrasonography, either palpable or not palpable. (Table 2) . Surgery was performed when high-risk or malignant lesions (C4 and C5) were detected and the final pathological diagnosis was recorded. All FNAC procedures were ultrasound guided and performed by two operators using personal protective equipment, specifically FFP2 or FFP3 masks, protective glasses and gloves. All operators used the aspiration technique with a 23-gauge needle connected to a 20 mL syringe with extension tubing. Following identification of the lesion by ultrasonography and alcohol disinfection of the skin, the needle was inserted into the suspected lesion. The syringe plunger was pulled back by the second operator, creating negative pressure, and cells were collected into the cutting edge of the needle. The needle was then withdrawn from the lesion, and its content expelled onto previously labelled slides. This is the first risky moment that may lead to aerosol/droplet formation. Smears were prepared by gently spreading the aspirated material, avoiding crush artefacts, using a second slide. The standard procedure prior to COVID-19 involved fixing one slide in 95% alcohol ( Figure 1 ) while the other was air-dried ( Figure 2 ). The rest of the specimen was put into a ready-to-use ThinPrep CytoLyt ® solution for subsequent automated processing with ThinPrep 5000 Processor ® (according to manufacturer's instruction; Hologic Corporation). The entire procedure was repeated twice. The slide containers, labelled with the patient data, were sent to the cytology laboratory for analysis along with a complete Cytopathology Requisition Form, including all the pertinent patient history. During the COVID-19 period, air-dried slides were no longer used due to the high risk of infectious aerosol formation while performing all the cyto-preparatory steps. We also compared the number of cytological procedures performed 2 months before and 2 months after the cut-off point (3 March During the pre-COVID-19 period ( (Table 3 ). Our results showed no significant difference between the two procedures. Specifically, we found no differences in the number of diagnoses classified as C1 and quality or quantity of cells. Importantly, for lesions suggestive of malignancy (C4 and C5), the concordance between cytological and histological results was excellent in both protocols. Therefore, at least in our initial experience, these results suggested the reliability of alcohol-based procedures in terms of diagnosis and safeness. Moreover, the overall number of breast FNAC procedures during the COVID-19 period was slightly lower compared to that of the pre-COVID-19 period (75 vs 100, respectively), and this was clearly related to the restrictions imposed by the Italian Government. In fact, the percentage of malignant results was higher during the COVID-19 period than that in the pre-COVID-19 period (52% vs 40%, respectively). Such restrictions ended in decreasing number of diagnostic procedures for both screening and follow-up programmes, favouring those dedicated to symptomatic patients. A still safer opportunity is given by liquid-based cytology. In this case, the specimen is directly collected in the fixative, which is warranted as it inactivates the virus and is processed in a closed system. Furthermore, centrifugation of aspirates allows cell blocks to be obtained, which can be submitted to histological evaluation and also immunohistochemical studies. This is the only procedure we still use for head and neck and lung specimens. The limitation is related to the need of having the instruments and experience in interpreting the slides. Given the risks associated with air-dried slide production, our results showed that this new protocol provided safe FNAC procedures during COVID-19 pandemic without compromising diagnostic conclusions. formed with FNAC in our hospital protected both patients and operators, making this experience useful for other departments dealing with pandemic. The authors declare that there is no conflict of interest. Approval by the Ethics Committee was obtained for this retrospective study. Patients' informed consent was obtained for this retrospective study. Data sharing is not applicable to this article as no new data were created or analysed in this study. Mauro Giuseppe Mastropasqua https://orcid. org/0000-0002-8306-0839 Aspiration biopsy of mammary tumors in diagnosis and research-a critical review of 2,200 cases Cytopathology of the breast. ASCP theory and practice of cytopathology IAC standardized reporting of breast fine-needle aspiration cytology, Yokohama 2016: a critical appraisal over a 2 year period Final diagnosis by fineneedle aspiration biopsy for definitive operation in breast cancer Fine-needle aspiration cytology vs. core biopsy in the diagnosis of breast lesions BSCC Code of practice-fine needle aspiration cytology Estimation of COVID-19 outbreak size in Italy Coronavirus Disease 2019 (COVID-19) in Italy Centers for Disease Control and Prevention. Laboratory biosafety guidelines for handling and processing specimens associated with SARSCoV Laboratory biosafety guidance related to the novel coronavirus (2019-nCoV). Interim guidance Biosafety in surgical pathology in the era of SARS-Cov2 pandemia. A statement of the Italian Society of Surgical Pathology and Cytology Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 Inactivation of Severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols Inactivation of surrogate coronaviruses on hard surfaces by health care germicides European Guidelines for quality assurance in breast cancer screening and diagnosis Air-dried smears for optimal diagnostic immunocytochemistry COVID-19 and breast fine needle aspiration cytology method: What should we change?